Nektar Therapeutics (NASDAQ:NKTR) is one of the Stocks With Huge Catalysts on the Horizon. On June 24, Nektar Therapeutics ...

Children/adolescents with atopic dermatitis and a sleep disorder faced a greater risk for ADHD, anxiety, depression and ...

Applying a daily emollient on infants younger than aged 9 weeks reduced the risk for atopic dermatitis by 16% at 24 months ...

Patients with AD treated with JAK inhibitors show higher risks for PE and deep vein thrombosis than those treated with ...

Strong recommendations presented for tapinarof cream, roflumilast cream, lebrikizumab, nemolizumab with concomitant topical therapy.

Oregon Health & Science University-led research is reporting that daily full-body emollient use starting before 9 weeks of ...

A poster at the Society for Pediatric Dermatology Annual Meeting presented an integrated safety analysis showing rare or no serious adverse events linked to topical Janus kinase inhibitor use in ...

New data highlight efficacy, safety, and time off treatment with as-needed ruxolitinib cream in pediatric atopic dermatitis.